News

Partner companies' news

Ideanomics Announces State-of-the-Art EV Experience Center and U.S. Manufacturing Facility in New Jersey to Accelerate Commercial Electrification
NEW YORK , April 7, 2022 /PRNewswire/ -- Ideanomics [1] (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric...
Acorn Management Partners, Administrator
— April 2022 — 644 views IDEX

Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022
SAN JOSE, Calif. , April 6, 2022 /PRNewswire/ --  Anixa Biosciences, Inc. [1] (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...
Acorn Management Partners, Administrator
— April 2022 — 630 views ANIX

Processa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase 2A Trial for the Treatment of Gastroparesis
HANOVER, MD, April 05, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage bioph...
Acorn Management Partners, Administrator
— April 2022 — 579 views PCSA

SAB Biotherapeutics Appoints Mark J. Ratain, MD, to the Company’s Board of Scientific Advisors
SIOUX FALLS, S.D., April 05, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics [1] ( Nasdaq: SABS [2] ), (SAB), a clinical-stage biopharmaceutical compan...
Acorn Management Partners, Administrator
— April 2022 — 637 views SABS

KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates
CELEBRATION, Fla., March 30, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty pharmaceutical company...
Acorn Management Partners, Administrator
— April 2022 — 638 views KMPH

Processa Pharmaceuticals Announces Year-End 2021 Results and Provides Corporate Update
HANOVER, Md., March 30, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical stage compa...
Acorn Management Partners, Administrator
— April 2022 — 598 views PCSA

Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase 1 Trial at Moffitt Cancer Center
SAN JOSE, Calif. , March 30, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. [1] (NASDAQ: ANIX), a biotechnology company focused on the treatment and...
Acorn Management Partners, Administrator
— April 2022 — 669 views ANIX

SAB Biotherapeutics Provides Company Update and Reports Full Year 2021 Financial Results
SIOUX FALLS, S.D., March 29, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics [1] ( Nasdaq: SABS [2] ), (SAB), a clinical-stage biopharmaceutical compa...
Acorn Management Partners, Administrator
— April 2022 — 575 views SABS

Ideanomics Finalizes Energica Motor Company Deal, Acquiring 70 Percent Ownership Stake in Pioneering High-Performance All-Electric Motorcycle Company
NEW YORK , March 28, 2022 /PRNewswire/ --  Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric v...
Acorn Management Partners, Administrator
— March 2022 — 789 views IDEX

KemPharm to Participate in Maxim’s 2022 Virtual Growth Conference
CELEBRATION, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery a...
Acorn Management Partners, Administrator
— March 2022 — 634 views KMPH

Processa Pharmaceuticals To Host Conference Call to Discuss Fourth Quarter 2021 Results and Provide Drug Development Update on March 30 at 4:30 p.m. EST
HANOVER, MD, March 23, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing...
Acorn Management Partners, Administrator
— March 2022 — 531 views PCSA

KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
CELEBRATION, Fla., March 21, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (the Company or KemPharm), a specialty pharmaceutical company ...
Acorn Management Partners, Administrator
— March 2022 — 681 views KMPH

Ideanomics Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
NEW YORK , March 18, 2022 /PRNewswire/ -- Ideanomics [1] (NASDAQ: IDEX) ("Ideanomics" or the "Company") today announced that it has received a not...
Acorn Management Partners, Administrator
— March 2022 — 612 views IDEX

Anixa Biosciences to Participate in the 2022 Virtual Growth Conference Hosted by M-Vest, a Division of Maxim Group LLC
SAN JOSE, Calif. , March 17, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. [1] (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...
Acorn Management Partners, Administrator
— March 2022 — 652 views ANIX

KemPharm Earns $1.975 Million Fee from Corium Following FDA Approval of the Corium Product ADLARITY® (donepezil transdermal system)
CELEBRATION, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (the Company, or KemPharm), a specialty pharmaceutical company...
Acorn Management Partners, Administrator
— March 2022 — 619 views KMPH

Ideanomics Delays Filing of Annual Report on Form 10-K
NEW YORK, March 15, 2022 /PRNewswire/ --  Ideanomics [1] (NASDAQ: IDEX) ("Ideanomics" or the "Company") today announced that the filing of its Annu...
Acorn Management Partners, Administrator
— March 2022 — 593 views IDEX

Processa Pharmaceuticals CEO Dr. David Young To Present at the Oppenheimer 32nd Annual Healthcare Conference
HANOVER, MD, March 10, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage bioph...
Acorn Management Partners, Administrator
— March 2022 — 601 views PCSA

KemPharm to Report Fourth Quarter and Full-Year 2021 Results
CELEBRATION, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery a...
Acorn Management Partners, Administrator
— March 2022 — 656 views KMPH

Ideanomics Secures Threshold in Energica Motor Company SpA Voluntary Tender Offer
NEW YORK, March 7, 2022 /PRNewswire/ -- (NASDAQ: IDEX) ("Ideanomics" or the "Company") is pleased to announce that it has provisionally passed the ...
Acorn Management Partners, Administrator
— March 2022 — 730 views IDEX

Ideanomics Provides Update on Timing of Fourth-Quarter and Full-Year 2021 Earnings Call
NEW YORK, Feb. 25, 2022 /PRNewswire/ -- Ideanomics, Inc. (NASDAQ: IDEX) ("Ideanomics" or the "Company") will delay the release of its 2021 fourth-q...
Acorn Management Partners, Administrator
— February 2022 — 647 views IDEX

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives